Status:
UNKNOWN
Predictors of Coronary Revascularization Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome
Lead Sponsor:
Assiut University
Conditions:
Diabetes Mellitus, Type 2 With Acute Coronary Syndrom
Eligibility:
All Genders
18-55 years
Brief Summary
* To explore the metabolic outcomes of PCI versus CABG in diabetic patients presented by ACS. * To verify the diagnostic and prognostic value of speckle tracking echocardiography in early detection of...
Detailed Description
Diabetes mellitus (DM) doubles the risk of cardiovascular disease and about 75% of deaths in diabetic patients are due to coronary artery disease. Studies performed during the 1980's and 90's demonstr...
Eligibility Criteria
Inclusion
- This study includes all patients (middle aged according to WHO 55 years of age) presented by ACS (STEMI , Non STEMI) from July 2020 to June2021 in both CCU Of Internal Medicine Departemennt and and EL Orman Assiut University Hospital of Cardiology and Cardiothoracic Surgery.
- ACS was defined and patients were managed according to the European Guidelines . Patients with acute chest pain and persistent (\>20 min) ST-segment elevation, i.e., STEMI generally reflected an acute total coronary occlusion. All patients received immediate myocardial reperfusion treatment by primary coronary intervention and angioplasty or fibrinolytic therapy, as appropriate. Patients with acute chest pain but no persistent ST-segment elevation, referred to as Non-STEMI included transient ST-segment elevation, persistent or transient ST-segment depression ,T-wave inversion, flat T waves or pseudo-normalized T waves or completely normal ECG at admission. Thygesen, K.; etal.2019
Exclusion
- -Ranal disease ie stage 3,4 or on dialysis.
- Advanced hepatic diseases ie(child B,C)
- Poor echo window including morbid obesity.
- Age \>18 and more than 55 years old
- Patients with previous history of significant valvular diseases,atrial fibrillation
- EF less than 40%
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04354740
Start Date
July 1 2020
End Date
July 1 2021
Last Update
April 22 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.